BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst.
The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches.
The San Jose, Calif.–based company offers a turnkey digital health platform for medtech and biopharma. BrightInsight developed its platform under a quality management system to support its customers’ global security, privacy, and regulatory requirements.
“This financing led by General Catalyst not only validates the market need for a global digital health platform for biopharma and medtech, but it also reinforces the tremendous progress we have made in the past year,” said Dr. Kal Patel, BrightInsight’s CEO and fo-founder.
“Our Series C round will enable BrightInsight to continue our hypergrowth and to support the development and launch of game-changing digital health solutions for our customers,” Patel said in a news release.
Hemant Taneja, managing director of General Catalyst and a co-founder of Livongo, will serve as a close advisor to BrightInsight. “We believe BrightInsight can redefine biopharma and medtech’s approach to regulated digital health by providing the underlying platform technology to build and scale their programs,” Taneja said. “Kal and the leadership team are addressing a pressing need and delivering a real benefit: allowing their customers to bring transformative digital health solutions to market more quickly and seamlessly.”
General Catalyst was an early investor in both fin-tech SaaS platform Stripe and digital health giant Livongo, which recently sold for $18.5 billion to Teledoc.
